Study | Reason for exclusion |
---|---|
Bai 2021 | Wrong study design |
ChiCTR‐IPR‐15006695 | Wrong intervention |
ChiCTR‐OPN‐16008147 | Wrong study design |
Dorrans 2020 | Wrong study design |
Elwehidy 2019 | Wrong intervention |
EUCTR2007‐000585‐21‐IE | Study not completed or confirmed |
EUCTR2008‐005464‐14‐DE | Wrong study design |
Gou 2020 | Wrong study design |
IRCT2016042527595N1 | Wrong patient population |
Jiang 2019 | Wrong study design |
JPRN‐UMIN000000895 | Wrong study design |
JPRN‐UMIN000001136 | Wrong study design |
JPRN‐UMIN000003854 | Wrong study design |
JPRN‐UMIN000013974 | Wrong study design |
Liu 2020 | Wrong comparator |
Muhsen 2019 | Wrong patient population |
NCT02914626 | Study not completed or confirmed |
NCT04970251 | Wrong study design |
RBR‐9wkw73j | Wrong patient population |
Song 2019 | Wrong study design |
Sun 2019 | Wrong study design |
TCTR20160826002 | Wrong intervention |
Wu 2020 | Wrong comparator |
Yang 2020 | Wrong comparator |
Yuryevich 2019 | Wrong study design |
Zarei 2021 | Wrong patient population |
Zhao 2020 | Wrong comparator |
anti‐VEGF: anti‐vascular endothelial growth factor IOP: intraocular pressure IVB: intravitreal bevacizumab mg: milligram MMC: mitomycin C NVG: neovascular glaucoma PRP: panretinal photocoagulation RCT: randomized controlled trial